Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

From weight loss injections to a newly approved pill, GLP-1 medications are everywhere– but many people are still unclear on ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Lynsey Macfadyen used to turn to food for comfort, until weight-loss medication helped her reshape her relationship with food ...

LIR Life Sciences is a leader in the dvancement of novel, needle-free drug delivery platforms for obesity treatment across ...

Injectable weight loss drugs such as semaglutide and tirzepatide have attracted huge attention, but new real-world data suggest they deliver far less weight loss than surgery outside clinical trials.

Multiple GLP-1 injection pens. GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

Key market opportunities for GLP-1 analogues include growth in the oral administration segment, expanding presence in Asia-Pacific and emerging markets, and strategic partnerships. Regulatory ...